MOXIHIP – Moxifloxacin Infusion (0.4% w/v)

MOXIHIP is a sterile intravenous infusion containing Moxifloxacin 400 mg/100 ml (0.4% w/v), a broad-spectrum fluoroquinolone antibiotic. It is indicated for the treatment of bacterial infections such as community-acquired pneumonia, complicated skin infections, and intra-abdominal infections. This ready-to-use IV solution is ideal for patients requiring parenteral antibiotic therapy.

Key Features:

• Broad-Spectrum Antibiotic: Effective against Gram-positive, Gram-negative, and atypical bacteria.

• Ready-to-Use Infusion: No dilution required, ensuring quick administration in clinical settings.

• High Tissue Penetration: Delivers therapeutic levels to infection sites effectively.

• Convenient Single-Dose Pack: Each 100 ml container ensures accurate dosing and sterility.

• Rapid Onset of Action: Ideal for serious or hospitalized infections requiring immediate treatment.

Indication:
Used in the management of respiratory tract infections, skin and soft tissue infections, and intra-abdominal infections.

Usage:
For intravenous (IV) use only, to be administered under strict medical supervision.